<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>308</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>9108020</PubmedId>
            <Abstract>OspA (outer surface protein A) is an abundant immunogenic lipoprotein of the Lyme disease spirochete Borrelia burgdorferi. The crystal structure of a soluble recombinant form of OspA was solved in a complex with the Fab fragment of mouse monoclonal antibody 184.1 and refined to a resolution of 1.9 A. OspA has a repetitive antiparallel beta topology with an unusual nonglobular region of "freestanding" sheet connecting globular N- and C-terminal domains. Arrays of residues with alternating charges are a predominant feature of the folding pattern in the nonglobular region. The 184.1 epitope overlaps with a well conserved surface in the N-terminal domain, and a hydrophobic cavity buried in a positively charged cleft in the C-terminal domain is a potential binding site for an unknown ligand. An exposed variable region on the C-terminal domain of OspA is predicted to be an important factor in the worldwide effectiveness of OspA-based vaccines.</Abstract>
            <ArticleYear>1997</ArticleYear>
            <ArticlePages>3584-9</ArticlePages>
            <ArticleTitle>Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>H</ForeName>
                </Author>
                <Author>
                    <LastName>Dunn</LastName>
                    <ForeName>J J</ForeName>
                </Author>
                <Author>
                    <LastName>Luft</LastName>
                    <ForeName>B J</ForeName>
                </Author>
                <Author>
                    <LastName>Lawson</LastName>
                    <ForeName>C L</ForeName>
                </Author>
            </Authors>
            <Affiliations>Biology Department, Brookhaven National Laboratory, Upton, NY 11973, USA.</Affiliations>
            <ArticleChemicalList>Antigens, Surface;Bacterial Outer Membrane Proteins;Bacterial Vaccines;Immunoglobulin Fab Fragments;Lipoproteins;OspA protein</ArticleChemicalList>
            <ArticleMeshHeadingsList>Amino Acid Sequence; Animals; Antigens, Surface(chemistry; immunology); Bacterial Outer Membrane Proteins(chemistry; immunology); Bacterial Vaccines; Borrelia burgdorferi Group(chemistry; immunology); Crystallization; Humans; Immunoglobulin Fab Fragments(chemistry; immunology); Lipoproteins; Lyme Disease(microbiology); Mice; Molecular Sequence Data; Protein Binding; Protein Folding</ArticleMeshHeadingsList>
            <Journal>
                <Volume>94</Volume>
                <Issue>8</Issue>
                <Title>Proceedings of the National Academy of Sciences of the United States of America</Title>
                <Issn>0027-8424</Issn>
                <MedlineTa>Proc Natl Acad Sci U S A</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Epitope of Fab 184.1 on Outer surface protein A</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>V30, S31, V32, D33, L34, P35, K44, E45, K46, Y52, D68, K69, N70, N71, S91, D92, D93, L94, G95, K117, D118, K119</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P0CL66.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>224326</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 2 and PDB 1OSP</LocationOfData>
                <EpitopeId>189939</EpitopeId>
                <ReferenceRegion>V30, S31, V32, D33, L34, P35, K44, E45, K46, Y52, D68, K69, N70, N71, S91, D92, D93, L94, G95, K117, D118, K119</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figures 1, 2, 4, 5, Table 1 and PDB 1OSP</LocationOfData>
                        <BCellId>164</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000000</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>224326</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Borrelia burgdorferi spirochetes</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Exact match to reference information</ImmunogenEvidenceCode>
                                <Route>Intraperitoneal (i.p.)</Route>
                                <DoseSchedule>Six doses of 1 mg of sonicated B. burgdorferi i.p. at 10 day intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Generation of the monoclonal antibody(ies) was previously described in the cited reference: Jiang et al. (1990) J Immunol 144(1): 284-289 [PMID: 2295795].</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.95</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of Fab 184.1 on OspA was determined from the crystal structure of the complex.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>184.1</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2b</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>184.1</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1OSP_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1OSP_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10090</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>Outer surface protein A</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P0CL66.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>224326</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1OSP</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>O</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>Paratope residues and contacts are not discussed in the paper.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>O: V30, S31, V32, D33, L34, P35, K44, E45, K46, Y52, D68, K69, N70, N71, S91, D92, D93, L94, G95, K117, D118, K119</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: ; L: ;</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>1200.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>800.0</ContactAreaForAntibody>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>O: V30, D33, L34, P35, S43, K44, E45, K46, Y52, K69, N70, N71, D92, D93, L94, G95, K117, D118, K119</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: S31, Y53, R99, D100, Y101, Y102; L: Y30, S31, R32, G50, S53, D66, W92</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>693.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>781.3</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

